Abstract:The development of various chemical methods has enabled scientists to decipher the distribution features and biological functions of RNA modifications in the past decade. In addition to modifying noncoding RNAs such as tRNAs and rRNAs, N6-methyladenosine (m6A) has been proven to be the most abundant internal chemical modification on mRNAs in eukaryotic cells and is also the most widely studied mRNA modification to date. Extensive studies have repeatedly demonstrated the important functions of m6A in various biological conditions, ranging from embryonic organ development to adult organ function and pathogenesis. Unlike DNA methylation which is relatively stable, the reversible m6A modification on mRNA is highly dynamic and easily influenced by various internal or external factors, such as cell type, developmental stage, nutrient supply, circadian rhythm, and environmental stresses.In this Account, we review our previous findings on the site selectivity mechanisms regulating m6A formation, as well as the physiological roles of m6A modification in cerebellum development and long-term memory consolidation. In our initial efforts to profile m6A in various types of mouse and human cells, we surprisingly found that the sequence motifs surrounding m6A sites were often complementary with the seed sequences of miRNAs. By manipulating the abundance of the miRNA biogenesis enzyme Dicer or individual miRNAs or mutating miRNA sequences, we were able to reveal a new role of nucleus localized miRNAs, which is to guide the m6A methyltransferase METTL3 to bind to mRNAs and to promote m6A formation. As a result, we partially answered the question of why only a small proportion of m6A motifs within an mRNA could have m6A modification at a certain time point. We further explored the functions of m6A modification in regulating brain development and brain functions. We found that cerebellum had the most severe defects when Mettl3 was knocked out in developing mouse embryonic brain and revealed that the underlying mechanisms could be attributed to aberrant mRNA splicing and enhanced cell apoptosis under m6A deficit conditions. On the other hand, knocking out Mettl3 in postnatal hippocampus did not cause morphological defects in the mouse brain but impaired the efficacy of long-term memory consolidation. Under learning stimuli, formation of m6A modifications could be detected on transcripts encoding proteins related to dendrite growth, synapse formation, and other memory related functions. Loss of m6A modifications on these transcripts would result in translation deficiency and reduced protein production, particularly in the translation of early response genes, and therefore would compromise the efficacy of long-term memory consolidation. Interestingly, excessive training sessions or increased training intensity could overcome such m6A deficiency related memory defects, which is likely due to the longer turnover cycle and the cumulative abundance of proteins throughout the training process. In addition to revealing the roles of m6A modification in regulating long-term memory formation, our work also demonstrated an effective method for studying memory formation efficacy. As the lack of an appropriate model for studying memory formation efficacy has been a long-lasting problem in the field of neural science, our hippocampus-specific postnatal m6A knockout model could also be utilized to study other questions related to memory formation efficacy.

N-6-methyladenosine (m6A) Promotes the Nuclear Retention of mRNAs with Intact 5' Splice Site Motifs

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

M6a-Binding Proteins: the Emerging Crucial Performers in Epigenetics

N6-methyladenosine-dependent Regulation of Messenger RNA Stability.

Nuclear M6a Reader YTHDC1 Regulates Mrna Splicing

N 6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein

Nuclear Retention Coupled with Sequential Polyadenylation Dictates Post-Transcriptional M6a 6 A Modification in the Nucleus

Fragile X Mental Retardation Protein Modulates the Stability of Its M6a-Marked Messenger RNA Targets.

Nuclear retention coupled with sequential polyadenylation dictates post-transcriptional m6A modification in the nucleus

The RNA-binding protein FMRP facilitates the nuclear export of N6-methyladenosine–containing mRNAs

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development

m6A enhances the phase separation potential of mRNA

Nuclear M6a Reader YTHDC1 Suppresses Proximal Alternative Polyadenylation Sites by Interfering with the 3′ Processing Machinery

N6-Methyladenosine on Mrna Facilitates a Phase-Separated Nuclear Body That Suppresses Myeloid Leukemic Differentiation

Effects of Exogenous N6-methyladenosine Incorporation on the Expression of Cellular mRNA Transcripts

YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA

N6-methyladenosine-dependent RNA Structural Switches Regulate RNA–protein Interactions

N6-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions

Structural Insights into N 6 -Methyladenosine (m 6 A) Modification in the Transcriptome

Understanding the redundant functions of the m6A-binding YTHDF proteins